84 related articles for article (PubMed ID: 11311495)
1. Cell differentiation and chemotherapy influence p53 and Mdm2 immunoreactivity in human HT29 colon cancer cells grown in scid mice.
Schumacher U; Adam E; Feldhaus S; Katoh M; Lane DP
Cancer Lett; 2001 May; 166(2):215-21. PubMed ID: 11311495
[TBL] [Abstract][Full Text] [Related]
2. Early signet ring cell carcinoma arising from colonic adenoma: the molecular profiling supports the adenoma-carcinoma sequence.
Bellan A; Cappellesso R; Lo Mele M; Peraro L; Balsamo L; Lanza C; Fassan M; Rugge M
Hum Pathol; 2016 Apr; 50():183-6. PubMed ID: 26997454
[TBL] [Abstract][Full Text] [Related]
3. The action of 5-fluorouracil on human HT29 colon cancer cells grown in SCID mice: mitosis, apoptosis and cell differentiation.
Sharma R; Adam E; Schumacher U
Br J Cancer; 1997; 76(8):1011-6. PubMed ID: 9376259
[TBL] [Abstract][Full Text] [Related]
4. Piperlongumine exerts cytotoxic effects against cancer cells with mutant p53 proteins at least in part by restoring the biological functions of the tumor suppressor.
Basak D; Punganuru SR; Srivenugopal KS
Int J Oncol; 2016 Apr; 48(4):1426-36. PubMed ID: 26848023
[TBL] [Abstract][Full Text] [Related]
5. MDR-1-overexpression in HT 29 colon cancer cells grown in SCID mice.
Schumacher U; Nehmann N; Adam E; Mukthar D; Slotki IN; Horny HP; Flens MJ; Schlegelberger B; Steinemann D
Acta Histochem; 2012 Oct; 114(6):594-602. PubMed ID: 22154301
[TBL] [Abstract][Full Text] [Related]
6. Colon cancer in a 16-year-old girl: signet-ring cell carcinoma without microsatellite instability--an unusual suspect.
Jain AK; Motil KJ; Olutoye OO; Cope-Yokoyama S; Egler RA; Tatevian N
J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):110-4. PubMed ID: 19172134
[No Abstract] [Full Text] [Related]
7. Photodynamic therapy resistant human colon carcinoma HT29 cells show cross-resistance to UVA but not UVC light.
Zacal N; Rainbow AJ
Photochem Photobiol; 2007; 83(3):730-7. PubMed ID: 17576382
[TBL] [Abstract][Full Text] [Related]
8. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
[TBL] [Abstract][Full Text] [Related]
9. Primary signet ring cell carcinoma of the colon and rectum.
Arifi S; Elmesbahi O; Amarti Riffi A
Bull Cancer; 2015 Oct; 102(10):880-8. PubMed ID: 26412710
[TBL] [Abstract][Full Text] [Related]
10. miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.
Han J; Li J; Tang K; Zhang H; Guo B; Hou N; Huang C
Exp Cell Res; 2017 Nov; 360(2):328-336. PubMed ID: 28928082
[TBL] [Abstract][Full Text] [Related]
11. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
[TBL] [Abstract][Full Text] [Related]
12. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
13. ERK mediated upregulation of death receptor 5 overcomes the lack of p53 functionality in the diaminothiazole DAT1 induced apoptosis in colon cancer models: efficiency of DAT1 in Ras-Raf mutated cells.
Thamkachy R; Kumar R; Rajasekharan KN; Sengupta S
Mol Cancer; 2016 Mar; 15():22. PubMed ID: 26956619
[TBL] [Abstract][Full Text] [Related]
14. 5‑FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53‑mutated colon cancer cells.
Akasaka T; Tsujii M; Kondo J; Hayashi Y; Ying J; Lu Y; Kato M; Yamada T; Yamamoto S; Inoue T; Tsujii Y; Maekawa A; Fujinaga T; Shiraishi E; Hiyama S; Inoue T; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
Int J Oncol; 2015 Jan; 46(1):63-70. PubMed ID: 25310623
[TBL] [Abstract][Full Text] [Related]
15. Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status.
Violette S; Poulain L; Dussaulx E; Pepin D; Faussat AM; Chambaz J; Lacorte JM; Staedel C; Lesuffleur T
Int J Cancer; 2002 Apr; 98(4):498-504. PubMed ID: 11920608
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells.
Raymond E; Louvet C; Tournigand C; Coudray AM; Faivre S; De Gramont A; Gespach C
Int J Oncol; 2002 Aug; 21(2):361-7. PubMed ID: 12118332
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
[TBL] [Abstract][Full Text] [Related]
18. Roles for negative cell regulator 14-3-3sigma in control of MDM2 activities.
Yang HY; Wen YY; Lin YI; Pham L; Su CH; Yang H; Chen J; Lee MH
Oncogene; 2007 Nov; 26(52):7355-62. PubMed ID: 17546054
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cytotoxicity of prenylated chalcone against tumour cells via disruption of the p53-MDM2 interaction.
Leão M; Soares J; Gomes S; Raimundo L; Ramos H; Bessa C; Queiroz G; Domingos S; Pinto M; Inga A; Cidade H; Saraiva L
Life Sci; 2015 Dec; 142():60-5. PubMed ID: 26475964
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
